Covid-19

Market Access

Nine for 2023, part one: a reflection on inflection

The Roman god Janus, as we are frequently reminded in January, was two faced and able to look forward to the coming year and backward to reflect on the past one.

Sales & Marketing

The Pandemic Treaty and the opportunity to end ‘vaccine apar...

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid.

Patients

What does the future of European healthcare look like?

After the “stress test” of COVID, how can the sector create resilient, sustainable healthcare systems for the long term?

News

Lawmakers accuse Pfizer of "pure greed" over COVID jab

Pfizer's decision to raise the price of its COVID-19 vaccine next year has prompted a rebuke from two Democrat senators in the US, who have accused the company of "unseemly profiteering."

R&D

Continuing to keep COVID-19 at bay – the pharmaphorum podcas...

Flying into London recently for the Jefferies Conference, Novavax’s EVP, chief commercial officer, and chief business officer John Trizzino, together with the comp

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Pfizer, BioNTech submit to FDA for Covid vaccine in under 5s

Pfizer and BioNTech have announced that they have submitted an Emergency Use Authorisation (EUA) to the US Food and Drug Administration (FDA) for their Omicron BA.4/BA.5-adapted bivalent CO